ArticleFrontiers in veterinary science2026
Case Report: Complete MRI-confirmed remission of presumptive meningoencephalitis of unknown origin in a Chihuahua using a steroid-free combination of leflunomide and mycophenolate mofetil.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Meningoencephalitis of unknown origin (MUO) is an idiopathic inflammatory disorder of the canine central nervous system predominantly affecting small-breed dogs. Standard treatment typically involves glucocorticoids; however, chronic steroid exposure carries substantial risk for adverse effects and may compromise long-term management. A 9-year-old, 2.5 kg female Chihuahua presented with 1 week of rightward circling, head tilt, and cervical stiffness. MRI revealed multifocal intra-axial hyperintensities involving the cerebellum, brainstem, and medulla with associated meningeal enhancement. CSF cytology demonstrated moderate lymphocytic pleocytosis with elevated protein. A steroid-free immunosuppressive protocol using leflunomide and mycophenolate mofetil was initiated. Neurologic signs progressively improved, and repeat MRI at 12 months documented complete resolution of inflammatory lesions. Both medications were continued for 2 years, during which serial hematologic and biochemical monitoring remained within normal limits. No adverse events occurred. This case provides, to the authors' knowledge, the first documented MRI-confirmed remission of MUO achieved with exclusive steroid-free immunosuppression. Relevant literature is reviewed to contextualize the immunopathogenesis of MUO and considerations for steroid-sparing strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.